1. MFSD4A inhibits the malignant progression of nasopharyngeal carcinoma by targeting EPHA2
   Huiyun Yang et al, 2022, Cell Death & Disease CrossRef
2. Involvement of ephrin receptor A4 in pancreatic cancer cell motility and invasion
   CHENGLI LIU et al, 2014, Oncology Letters CrossRef
3. WIP1 regulates the proliferation and invasion of nasopharyngeal carcinoma in vitro
   Yongquan Zhang et al, 2014, Tumor Biology CrossRef
4. Integrated Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) and Isobaric Tags for Relative and Absolute Quantitation (iTRAQ) Quantitative Proteomic Analysis Identifies Galectin-1 as a Potential Biomarker for Predicting Sorafenib Resistance in Liver Cancer*
   Chao-Chi Yeh et al, 2015, Molecular & Cellular Proteomics CrossRef
5. Identification of DNA aptamers that specifically targets EBV+ nasopharyngeal carcinoma via binding with EphA2/CD98hc complex
   Yaqi Chen et al, 2022, Biochemical and Biophysical Research Communications CrossRef
6. EphA2 inhibits SRA01/04 cells apoptosis by suppressing autophagy via activating PI3K/Akt/mTOR pathway
   Jing Han et al, 2021, Archives of Biochemistry and Biophysics CrossRef
7. Ephrin receptor A2 is an epithelial cell receptor for Epstein–Barr virus entry
   Hua Zhang et al, 2018, Nature Microbiology CrossRef
8. Heterozygous p53-R280T Mutation Enhances the Oncogenicity of NPC Cells Through Activating PI3K-Akt Signaling Pathway
   Zhen-Qi Qin et al, 2020, Frontiers in Oncology CrossRef
9. Ephrin type-A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3-kinase/Akt signalling pathway
   YUNYUN WANG et al, 2015, Molecular Medicine Reports CrossRef